Neil Gallagher, President, Head of R&D at Syndax Pharmaceuticals Inc (SNDX), sold 4,618 shares at $15.50 ($72K) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Open-market sale of $72k SNDX by President, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.